Search

Your search keyword '"Mes-Masson Anne-Marie"' showing total 1,147 results

Search Constraints

Start Over You searched for: Author "Mes-Masson Anne-Marie" Remove constraint Author: "Mes-Masson Anne-Marie"
1,147 results on '"Mes-Masson Anne-Marie"'

Search Results

3. Molecular landscape and functional characterization of centrosome amplification in ovarian cancer

6. Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent

7. Predictive Model for Assessment of Pathological Response of Colorectal Liver Metastases to Chemotherapy from CT Images

8. Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer

9. Necdin modulates proliferative cell survival of human cells in response to radiation-induced genotoxic stress

10. Re-assigning the histologic identities of COV434 and TOV-112D ovarian cancer cell lines

11. An essential role for Ran GTPase in epithelial ovarian cancer cell survival

12. The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles

13. BMP-2 signaling in ovarian cancer and its association with poor prognosis

14. Immunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors

15. Ebp1 expression in benign and malignant prostate

16. Influence of monolayer, spheroid, and tumor growth conditions on chromosome 3 gene expression in tumorigenic epithelial ovarian cancer cell lines

17. Characterization of three new serous epithelial ovarian cancer cell lines

18. Haplotype analysis of TP53 polymorphisms, Arg72Pro and Ins16, in BRCA1 and BRCA2 mutation carriers of French Canadian descent

19. Global gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroids

20. Comparative proteome analysis of human epithelial ovarian cancer

21. Characterization of EN-1078D, a poorly differentiated human endometrial carcinoma cell line: a novel tool to study endometrial invasion in vitro

22. Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families

24. Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression

27. The journey from bench to bedside—it takes a science village.

28. Improved overall survival in patients with high-grade serous ovarian cancer is associated with CD16a+ immunologic neighborhoods containing NK cells, T cells and macrophages

30. Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

32. Clinicopathological features of women with epithelial ovarian cancer and double heterozygosity for BRCA1 and BRCA2: A systematic review and case report analysis

33. A tumor-restricted glycoform of podocalyxin is a highly selective marker of immunologically cold high-grade serous ovarian carcinoma

35. A senescence-like state is beneficial for ovarian cancer treatment

36. A functionally impaired missense variant identified in French Canadian families implicates FANCI as a candidate ovarian cancer-predisposing gene

41. Homogeneity in immune features between colorectal liver metastases better identifies patients with good prognosis compared to pathological response to preoperative chemotherapy

42. Author Reply to Peer Reviews of Predicting developmental relationships of tumor resident and circulating T cells in ovarian cancer

43. The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

44. Spatial Organization and Molecular Correlation of Tumor-Infiltrating Lymphocytes Using Deep Learning on Pathology Images

45. Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers

46. Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context

47. Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas

48. Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types

49. Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas

50. Systematic Analysis of Splice-Site-Creating Mutations in Cancer

Catalog

Books, media, physical & digital resources